Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. V. Lubennikova
The Prospects for Cisplatin and Nab-Paclitaxel Combination Therapy in Patients With Pre-Treated Triple-Negative Breast Cancer. Description of the Clinical Case.
Medical Council
Pharmacoeconomic Analysis of Using Cyclin-Dependent Kinase 4 and 6 Inhibitors in the First Line Treatment of HR-positive HER2-negative Advanced Breast Cancer
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
Related publications
Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Cisplatin in Combination With Zoledronic Acid: A Synergistic Effect in Triple-Negative Breast Cancer Cell Lines
International Journal of Oncology
Cancer Research
Oncology
The Results of a Study of Chemotherapy With Bevacizumab, Oxaliplatin and Paclitaxel in Patients With Metastatic Triple Negative Breast Cancer
Malignant tumours
Impact of Radiation Therapy on Survival in Patients With Triple‑negative Breast Cancer
Oncology Letters
Cancer Research
Oncology
Nab-Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer With Visceral Crisis: Evaluation of Efficacy and Tolerability in Clinical Practice
Medical Council
The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer
Cancer Management and Research
Oncology
MiR-34b Is Associated With Clinical Outcome in Triple-Negative Breast Cancer Patients
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Severe and Prolonged Lymphopenia Observed in Patients Treated With Bendamustine and Erlotinib for Metastatic Triple Negative Breast Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
